Edição |
Título |
Arquivo |
Volume 31, Nº 38 (2024) |
1,3,4-Oxadiazole: An Emerging Scaffold to Inhibit the Thymidine Phosphorylase as an Anticancer Agent |
 (Eng)
|
Murmu A., Banjare P., Matore B., Roy P., Singh J.
|
Volume 31, Nº 18 (2024) |
A Comprehensive Review on the State of the Art of Breast Cancers in Italy |
 (Eng)
|
Iacopetta D., Ceramella J., Catalano A., Rosano C., Mariconda A., Giuzio F., Bonofiglio D., Saturnino C., Longo P., Sinicropi M.
|
Volume 31, Nº 17 (2024) |
A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma |
 (Eng)
|
Wang T., Chen P., Li T., Li J., Zhao D., Meng F., Zhao Y., Zheng Z., Liu X.
|
Volume 31, Nº 38 (2024) |
A Novel Gene Signature based on Immune Cell Infiltration Landscape Predicts Prognosis in Lung Adenocarcinoma Patients |
 (Eng)
|
Ma C.
|
Volume 31, Nº 32 (2024) |
A Novel Phytocolorant, Neoxanthin, as a Potent Chemopreventive: Current Progress and Future Prospects |
 (Eng)
|
Parida S., Jena M., Behera A., Mandal A., Nayak R., Patra S.
|
Volume 31, Nº 2 (2024) |
A Quinquennial Review of Potent LSD1 Inhibitors Explored for the Treatment of Different Cancers, with Special Focus on SAR Studies |
 (Eng)
|
Sheikh K., Iqubal A., Alam M., Akhter M., Khan M., Ehtaishamul Haque S., Parvez S., Jahangir U., Amir M., Khanna S., Shaquiquzzaman M.
|
Volume 31, Nº 12 (2024) |
A Review on Graphene Analytical Sensors for Biomarker-based Detection of Cancer |
 (Eng)
|
Patil S., Patil N., Mahajan M., Madhavi V., Gopinath S., Ramanathan S., More M., Patil K.
|
Volume 31, Nº 8 (2024) |
A Review on Shikonin and its Derivatives as Potent Anticancer Agents Targeted against Topoisomerases |
 (Eng)
|
Olatunde O., Yong J., Lu C., Ming Y.
|
Volume 31, Nº 30 (2024) |
A Review on the Anticancer Activity of Carbazole-based Tricyclic Compounds |
 (Eng)
|
Zhang H., Zhang W., Zhu M., Awadasseid A.
|
Volume 31, Nº 19 (2024) |
A Review on the Efficacy and Safety of Intrathecal Administration of Novel Medications for Leptomeningeal Metastases in Solid Cancers |
 (Eng)
|
Jafari F., Nodeh M., Hosseinjani H., Baharara H., Azad S., Arasteh O., Johnston T., Sahebkar A.
|
Volume 31, Nº 30 (2024) |
A Review on the use of Synthetic and Recombinant Antigens for the Immunodiagnosis of Tegumentary Leishmaniasis |
 (Eng)
|
Silva K., Ribeiro A., Gandra I., Resende C., da Silva Lopes L., Couto C., de Araujo Freire V., Barcelos I., Pereira S., Xavier S., da Paz M., Giunchetti R., Chávez-Fumagalli M., Gonçalves A., Coelho E., Galdino A.
|
Volume 31, Nº 26 (2024) |
A Structure-based Data Set of Protein-peptide Affinities and its Nonredundant Benchmark: Potential Applications in Computational Peptidology |
 (Eng)
|
Wang S., Ye H., Shang S., Li Z., Peng Y., Zhou P.
|
Volume 31, Nº 38 (2024) |
A Systematic Patent Review (2008-2023) for Treatment in Pregnancy |
 (Eng)
|
Pereira K., Pacheco C., Alves I., Haas S.
|
Volume 31, Nº 42 (2024) |
Acknowledgements to Reviewers |
 (Eng)
|
|
Volume 31, Nº 7 (2024) |
Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases |
 (Eng)
|
Pi Z., Qiu X., Liu J., Shi Y., Zeng Z., Xiao R.
|
Volume 31, Nº 40 (2024) |
Activation of Stimulator of Interferon Genes (STING): Promising Strategy to Overcome Immune Resistance in Prostate Cancer |
 (Eng)
|
Alnukhali M., Altabbakh O., Farooqi A., Pollack A., Daunert S., Deo S., Tao W.
|
Volume 31, Nº 6 (2024) |
Administration of Inhibitory Molecules through Nanoparticles in Breast Cancer Therapy |
 (Eng)
|
Quijia C., Enríquez A., Zappia C., Peroni R., Chorilli M.
|
Volume 31, Nº 31 (2024) |
Aducanumab in Alzheimers Disease: A Critical Update |
 (Eng)
|
Ashique S., Sirohi E., Kumar S., Rihan M., Mishra N., Bhatt S., Gautam R., Singh S., Gupta G., Chellappan D., Dua K.
|
Volume 31, Nº 23 (2024) |
Advances in Chitosan-based Drug Delivery Systems in Melanoma: A Narrative Review |
 (Eng)
|
Dana P., Hallajzadeh J., Asemi Z., Mansournia M., Yousefi B.
|
Volume 31, Nº 21 (2024) |
Advances in Drug Therapy for Gastrointestinal Stromal Tumour |
 (Eng)
|
Liu J., Li J., Zhu Y., Jing R., Ding S., Zhang J., Zhao L., Chen Y., Shen J.
|
Volume 31, Nº 13 (2024) |
Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine |
 (Eng)
|
Dhanjal D., Singh R., Sharma V., Nepovimova E., Adam V., Kuca K., Chopra C.
|
Volume 31, Nº 41 (2024) |
Advances in the Development of Carbonic Anhydrase Inhibitors as New Antiprotozoal Agents |
 (Eng)
|
Ortiz-Perez E., Vazquez-Jimenez L., Paz-Gonzalez A., Delgado-Maldonado T., González-González A., Gaona-Lopez C., Moreno-Herrera A., Vazquez K., Rivera G.
|
Volume 31, Nº 12 (2024) |
Advances in the Treatment of Autism Spectrum Disorder: Current and Promising Strategies |
 (Eng)
|
Yenkoyan K., Ounanian Z., Mirumyan M., Hayrapetyan L., Zakaryan N., Sahakyan R., Bjørklund G.
|
Volume 31, Nº 38 (2024) |
Advances of Oxidative Stress Impact in Periodontitis: Biomarkers and Effective Targeting Options |
 (Eng)
|
Pouliou C., Piperi C.
|
Volume 31, Nº 6 (2024) |
Aging and Diabetic Kidney Disease: Emerging Pathogenetic Mechanisms and Clinical Implications |
 (Eng)
|
Chen Y., Kanwar Y., Chen X., Zhan M.
|
Volume 31, Nº 33 (2024) |
AI: A New Solution for Old Issues of Carotid Atherosclerotic Plaque |
 (Eng)
|
Boccatonda A., Cocco G., Schiavone C.
|
Volume 31, Nº 8 (2024) |
Aldehyde Dehydrogenases as Promising Targets for Treating Toxic Aldehyde-related Diseases |
 (Eng)
|
Chen Y., Li X.
|
Volume 31, Nº 32 (2024) |
Alkaloids as Additional Weapons in the Fight against Breast Cancer: A Review |
 (Eng)
|
Chahat ., Jha K., Bhatia R., Chawla P.
|
Volume 31, Nº 20 (2024) |
An Investigation into the Effects of Chemical, Pharmaceutical, and Herbal Compounds on Neuroglobin: A Literature Review |
 (Eng)
|
Hamedani S., Pourmasoumi M., Askari G., Bagherniya M., Sathyapalan T., Sahebkar A.
|
Volume 31, Nº 33 (2024) |
An Investigation of Pharmacokinetic Interaction of Vericiguat with Apigenin based on a Newly Developed Ultra-performance Liquid Chromatography-tandem Mass Spectrometry Assay |
 (Eng)
|
Zhang E., Chen C., Wang Y., Weng Q., Xu R., Lin J.
|
Volume 31, Nº 28 (2024) |
An Update of Extracellular Vesicle Involvement in Different Steps of Cancer Metastasis and Targeting Strategies |
 (Eng)
|
Mortezaee K., Majidpoor J.
|
Volume 31, Nº 29 (2024) |
An Update on Glutathione's Biosynthesis, Metabolism, Functions, and Medicinal Purposes |
 (Eng)
|
Gasmi A., Nasreen A., Lenchyk L., Lysiuk R., Peana M., Shapovalova N., Piscopo S., Komisarenko M., Shanaida M., Smetanina K., Antonyak H., Fira L., Lykhatskyi P., Fira D., Bjørklund G.
|
Volume 31, Nº 19 (2024) |
An Update on Parkinsons Disease and its Neurodegenerative Counterparts |
 (Eng)
|
Adam H., Gopinath S., Arshad M., Adam T., Subramaniam S., Hashim U.
|
Volume 31, Nº 36 (2024) |
An Updated Review For Hyperuricemia and Gout Management; Special Focus on the Available Drug Delivery Systems and Clinical Trials |
 (Eng)
|
Karantas I., Miliotou A., Siafaka P.
|
Volume 31, Nº 23 (2024) |
An Updated Review on the Significance of DNA and Protein Methyltransferases and De-methylases in Human Diseases: From Molecular Mechanism to Novel Therapeutic Approaches |
 (Eng)
|
Ghanbari M., Khosroshahi N., Alamdar M., Abdi A., Aghazadeh A., Feizi M., Haghi M.
|
Volume 31, Nº 30 (2024) |
Anticancer Potential of ACEIs/ARBs Administration in Colorectal Cancer |
 (Eng)
|
Wang X., Jing H.
|
Volume 31, Nº 15 (2024) |
Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma |
 (Eng)
|
Trojan A., Lone Y., Briceno I., Trojan J.
|
Volume 31, Nº 24 (2024) |
Anti-gout and Urate-lowering Potentials of Curcumin: A Review from Bench to Beside |
 (Eng)
|
Jafari-Nozad A., Jafari A., Yousefi S., Bakhshi H., Farkhondeh T., Samarghandian S.
|
Volume 31, Nº 1 (2024) |
Anti-obesity Properties of Phytochemicals: Highlighting their Molecular Mechanisms against Obesity |
 (Eng)
|
Poulios E., Koukounari S., Psara E., Vasios G., Sakarikou C., Giaginis C.
|
Volume 31, Nº 18 (2024) |
Antiviral Compounds to Address Influenza Pandemics: An Update from 2016-2022 |
 (Eng)
|
Romeo R., Legnani L., Chiacchio M., Giofrè S., Iannazzo D.
|
Volume 31, Nº 9 (2024) |
Application of Nanoparticles for Efficient Delivery of Quercetin in Cancer Cells |
 (Eng)
|
Homayoonfal M., Aminianfar A., Asemi Z., Yousefi B.
|
Volume 31, Nº 26 (2024) |
Application of Quercetin and its Novel Formulations in the Treatment of Malignancies of Central Nervous System: An Updated Review of Current Evidence based on Molecular Mechanisms |
 (Eng)
|
Jamshidi-Mouselou M., Hashemi A., Jamshidi-Mouselou M., Farkhondeh T., Pourhanifeh M., Samarghandian S.
|
Volume 31, Nº 39 (2024) |
Application Research Progress of Nanomaterial Graphene and its Derivative Complexes in Tumor Diagnosis and Therapy |
 (Eng)
|
Cui L., Fan L., Shen Z.
|
Volume 31, Nº 40 (2024) |
Artificial Intelligence Application for Anti-tumor Drug Synergy Prediction |
 (Eng)
|
Peng Z., Ding Y., Zhang P., Lv X., Li Z., Zhou X., Huang S.
|
Volume 31, Nº 6 (2024) |
Association between Statins Types with Incidence of Liver Cancer: An Updated Meta-analysis |
 (Eng)
|
Zhang X., Lou D., Fu R., Wu F., Zheng D., Ma X.
|
Volume 31, Nº 25 (2024) |
Association of Cystatin C Level with All-cause Mortality in Patients with Liver Cirrhosis: A Meta-analysis |
 (Eng)
|
Wang X., Xu W., Yao L., Jie Y., Gao Z., Fan Y.
|
Volume 31, Nº 39 (2024) |
Association of Neurokinin-1 Receptor Signaling Pathways with Cancer |
 (Eng)
|
Rodriguez F., Covenas R.
|
Volume 31, Nº 21 (2024) |
Association of PD-L1 Expression with Clinicopathologic Characters in Gastric Cancer: A Comprehensive Meta-analysis |
 (Eng)
|
Han Z., Wang N., Qiao Q., He X., Wang N.
|
Volume 31, Nº 36 (2024) |
Bacterial Polyhydroxyalkanoates-based Therapeutics-delivery Nano-systems |
 (Eng)
|
Durán-Lara E., Rafael D., Andrade F., G. O., Vijayakumar S.
|
Volume 31, Nº 24 (2024) |
Berberine Decreases Thrombosis Potential Induced by a High-choline Diet by Inhibiting CutC Enzyme |
 (Eng)
|
Qu H., Zhang Y., Shi J., Zhao Y., Gao J., Gao Z., Shi D.
|
Volume 31, Nº 10 (2024) |
Berberine: Pharmacological Features in Health, Disease and Aging |
 (Eng)
|
Gasmi A., Asghar F., Zafar S., Oliinyk P., Khavrona O., Lysiuk R., Peana M., Piscopo S., Antonyak H., Pen J., Lozynska I., Noor S., Lenchyk L., Muhammad A., Vladimirova I., Dub N., Antoniv O., Tsal O., Upyr T., Bjørklund G.
|
Volume 31, Nº 13 (2024) |
Beyond the Dusty Fog: Local Eye Drop Therapy and Potentially New Treatment Alternatives in Pseudoexfoliative Glaucoma |
 (Eng)
|
Zeppieri M., Musa M.
|
Volume 31, Nº 26 (2024) |
Bile Acid-conjugate as a Promising Anticancer Agent: Recent Progress |
 (Eng)
|
Rathod N., Mishra S.
|
Volume 31, Nº 37 (2024) |
Biochemistry, Mechanistic Intricacies, and Therapeutic Potential of Antimicrobial Peptides: An Alternative to Traditional Antibiotics |
 (Eng)
|
Dwivedi M., Parmar M., Mukherjee D., Yadava A., Yadav H., Saini N.
|
Volume 31, Nº 25 (2024) |
Biogenic Carbon Quantum Dots: Synthesis and Applications |
 (Eng)
|
Deb A., Chowdhury D.
|
Volume 31, Nº 19 (2024) |
Biology of Tenascin C and its Role in Physiology and Pathology |
 (Eng)
|
Abedsaeidi M., Hojjati F., Tavassoli A., Sahebkar A.
|
Volume 31, Nº 28 (2024) |
Biomarkers for Diagnosing and Treating Fetal Growth Restriction |
 (Eng)
|
Wu M., He J., Chen Y., Wan F., Tang H., Yin C., He H., Yu H., Yuan C.
|
Volume 31, Nº 31 (2024) |
Blood-based microRNAs as Potential Diagnostic Biomarkers for Melanoma: A Meta-Analysis |
 (Eng)
|
Aalami A., Abdeahad H., Mokhtari A., Aalami F., Amirabadi A., Aliabadi E., Pirzade O., Sahebkar A.
|
Volume 31, Nº 41 (2024) |
Caffeic Acid Phenethyl Ester: A Potential Therapeutic Cancer Agent? |
 (Eng)
|
Bjørklund G., Storchylo O., Peana M., Hangan T., Lysiuk R., Lenchyk L., Koshovyi O., Antonyak H., Hudz N., Chirumbolo S.
|
Volume 31, Nº 32 (2024) |
Cancer Pathways Targeted by Berberine: Role of microRNAs |
 (Eng)
|
Ali M., Mishra D., Singh R.
|
Volume 31, Nº 25 (2024) |
Carbon Nanocomposites-based Electrochemical Sensors and Biosensors for Biomedical Diagnostics |
 (Eng)
|
Kannan P., Maduraiveeran G.
|
Volume 31, Nº 31 (2024) |
Cardiac Organoids: A 3D Technology for Disease Modeling and Drug Screening |
 (Eng)
|
Zhu Y., Yang S., Zhang T., Ge Y., Wan X., Liang G.
|
Volume 31, Nº 10 (2024) |
Cardiospecific Troponins as Laboratory Biomarkers of Myocardial Cell Injury in Hypertension: A Mini-Review |
 (Eng)
|
Chaulin A.
|
Volume 31, Nº 27 (2024) |
CAR-T Therapy in Relapsed Refractory Multiple Myeloma |
 (Eng)
|
Ding H., Wu Y.
|
Volume 31, Nº 13 (2024) |
CD155-TIGIT Axis as a Therapeutic Target for Cancer Immunotherapy |
 (Eng)
|
Mu Y., Guan X.
|
Volume 31, Nº 17 (2024) |
Chalcone Derivatives as Antibacterial Agents: An Updated Overview |
 (Eng)
|
de Oliveira A., Cenci A., Gonçalves L., Thedy M., Justino A., Braga A., Meier L.
|
Volume 31, Nº 7 (2024) |
Challenges of Natural Anticancer and Anti-inflammatory Agents |
 (Eng)
|
Scotti M., Scotti L.
|
Volume 31, Nº 14 (2024) |
Chemical Strategies towards the Development of Effective Anticancer Peptides |
 (Eng)
|
Li C., Jin K.
|
Volume 31, Nº 34 (2024) |
CircRNAs as a Novel Class of Potential Diagnostic Biomarkers in Bipolar Disorders |
 (Eng)
|
Asemi R., Ebrahimi A., Hamblin M., Mirzaei H., Asemi Z.
|
Volume 31, Nº 6 (2024) |
Circulating Levels of 5-HT and BDNF in Adults with Autism Spectrum Conditions: An Investigation in a Sample of Subjects with Autism Spectrum Disorder, their First-degree Relatives and Controls |
 (Eng)
|
Carpita B., Stagnari R., Palego L., Baroni D., Massimetti G., Nardi B., Cremone I., Betti L., Giannaccini G., Dell'Osso L.
|
Volume 31, Nº 14 (2024) |
Coenzyme Q10 for Enhancing Physical Activity and Extending the Human Life Cycle |
 (Eng)
|
Bjørklund G., Semenova Y., Gasmi A., Ruwan Indika N., Hrynovets I., Lysiuk R., Lenchyk L., Uryr T., Yeromina H., Peana M.
|
Volume 31, Nº 2 (2024) |
Cognitive Benefits of Sodium-Glucose Co-Transporters-2 Inhibitors in the Diabetic Milieu |
 (Eng)
|
Yaribeygi H., Maleki M., Sathyapalan T., Rizzo M., Sahebkar A.
|
Volume 31, Nº 27 (2024) |
Combining Mendelian Randomization Analysis and 3D-QSAR to Investigate the Effectiveness of a New Series of Hydroxyquinolines in Osteoarthritis |
 (Eng)
|
Lian Z., Su K., Lu H., Qu C., Ma X.
|
Volume 31, Nº 30 (2024) |
Comprehensive Analysis of Ligand-receptor Interactions in Colon Adenocarcinoma to Identify of Tumor Microenvironment Oxidative Stress and Prognosis Model |
 (Eng)
|
Hu J., Zhu W., Wang W., Yue X., Zhao P., Kong D.
|
Volume 31, Nº 17 (2024) |
Comprehensive scRNA-seq Analysis and Identification of CD8_+T Cell Related Gene Markers for Predicting Prognosis and Drug Resistance of Hepatocellular Carcinoma |
 (Eng)
|
Cao L., Liu M., Ma X., Rong P., Zhang J., Wang W.
|
Volume 31, Nº 26 (2024) |
Computational Methods and Artificial Intelligence in the Discovery and Development of Therapeutic Peptides and Beyond |
 (Eng)
|
Huang J.
|
Volume 31, Nº 20 (2024) |
Computational Protein Design - Where it goes? |
 (Eng)
|
Xu B., Chen Y., Xue W.
|
Volume 31, Nº 12 (2024) |
Construction of RNA Methylation Modification-immune-related lncRNA Molecular Subtypes and Prognostic Scoring System in Lung Adenocarcinoma |
 (Eng)
|
Wang J., Shu J.
|
Volume 31, Nº 19 (2024) |
Crosstalk between Oxidative Stress and Inflammation Induced by Ionizing Radiation in Healthy and Cancerous Cells |
 (Eng)
|
Mohammadgholi M., Hosseinimehr S.
|
Volume 31, Nº 24 (2024) |
Curcumin and its Derivatives Targeting Multiple Signaling Pathways to Elicit Anticancer Activity: A Comprehensive Perspective |
 (Eng)
|
Fatima F., Chourasiya N., Mishra M., Kori S., Pathak S., Das R., Kashaw V., Iyer A., Kashaw S.
|
Volume 31, Nº 41 (2024) |
Curcumin Derivatives Linked to a Reduction of Oxidative Stress in Mental Dysfunctions and Inflammatory Disorders |
 (Eng)
|
Dhiman P., Malik N.
|
Volume 31, Nº 33 (2024) |
Curcuminoid Chalcones: Synthesis and Biological Activity against the Human Colon Carcinoma (Caco-2) Cell Line |
 (Eng)
|
Olender D., Sowa-Kasprzak K., Pawełczyk A., Skóra B., Zaprutko L., Szychowski K.
|
Volume 31, Nº 21 (2024) |
Curcuminoids as Cell Signaling Pathway Modulators: A Potential Strategy for Cancer Prevention |
 (Eng)
|
Noor A., Shafi S., Sehar N., Qadir I., Bilquees ., Rashid S., Arafah A., Rasool S., Dar N., Masoodi M., Rehman M.
|
Volume 31, Nº 26 (2024) |
Current Computational Methods for Protein-peptide Complex Structure Prediction |
 (Eng)
|
Yang C., Xu X., Xiang C.
|
Volume 31, Nº 26 (2024) |
Current Development of Data Resources and Bioinformatics Tools for Anticoronavirus Peptide |
 (Eng)
|
Li B., Li M., Lu C., Wu Y., Chen H., He B.
|
Volume 31, Nº 35 (2024) |
Current Evidence on Dietary Factors and Kidney Allograft Function in Kidney Transplant Recipients: A Systematic Review |
 (Eng)
|
Nosrati-Oskouie M., Salavatizadeh M., Ghorban Sabbagh M., Aghili-Moghaddam N., Tarighat-Esfanjani A., Sahebkar A.
|
Volume 31, Nº 42 (2024) |
Current Targets and Future Directions of Positive Inotropes for Heart Failure |
 (Eng)
|
Fairuz S., Ang C., Mraiche F., Goh J.
|
Volume 31, Nº 25 (2024) |
Current Trends in the Development of Electrochemical Biosensor for Detecting Analytes from Sweat |
 (Eng)
|
Singh A., Sharma A., Dubey A., Arya S.
|
Volume 31, Nº 27 (2024) |
Current Understanding of Androgen Signaling in Prostatitis and its Treatment: A Review |
 (Eng)
|
Cabeza M.
|
Volume 31, Nº 22 (2024) |
Detection of Circulating Cell-free DNA to Diagnose Hepatocellular Carcinoma in Chinese Population: A Systematic Review and Meta-analysis |
 (Eng)
|
Aalami A., Aalami F., Aliabadi E., Amirabadi A., Sahebkar A.
|
Volume 31, Nº 17 (2024) |
Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction |
 (Eng)
|
Li X., Lei J., Shi Y., Peng Z., Gong M., Shu X.
|
Volume 31, Nº 41 (2024) |
Development and Validation of the Diagnostic Model of 7 Gene in Endometriosis |
 (Eng)
|
Zhu R., Liu Y., Zhou J., Lv Z., Shi K., Xiong J.
|
Volume 31, Nº 16 (2024) |
Development in the Inhibition of Dengue Proteases as Drug Targets |
 (Eng)
|
Akram M., Hameed S., Hassan A., Khan K.
|
Volume 31, Nº 5 (2024) |
Development of Neuroprotective Agents for the Treatment of Alzheimer's Disease using Conjugates of Serotonin with Sesquiterpene Lactones |
 (Eng)
|
Neganova M., Liu J., Aleksandrova Y., Vasilieva N., Semakov A., Yandulova E., Sukocheva O., Balakin K., Klochkov S., Fan R.
|
Volume 31, Nº 29 (2024) |
Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment |
 (Eng)
|
Ma C., Cui S., Xu R.
|
Volume 31, Nº 38 (2024) |
Differential Effect of 4H-Benzo[d] [1, 3]oxazines on the Proliferation of Breast Cancer Cell Lines |
 (Eng)
|
Fraire-Soto I., Araujo-Huitrado J., Granados-López A., Segura-Quezada L., Ortiz-Alvarado R., Herrera M., Gutiérrez-Hernández R., Reyes-Hernández C., López-Hernández Y., Tapia-Juárez M., Negrete-Díaz J., Chacón-García L., Solorio-Alvarado C., López J.
|
Volume 31, Nº 7 (2024) |
Dihydrofolate Reductase (DHFR) Inhibitors: A Comprehensive Review |
 (Eng)
|
Sehrawat R., Rathee P., Khatkar S., Akkol E., Khayatkashani M., Nabavi S., Khatkar A.
|
Volume 31, Nº 9 (2024) |
Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19) |
 (Eng)
|
De S.
|
Volume 31, Nº 16 (2024) |
Discovery of Novel Inhibitors of Cruzain Cysteine Protease of Trypanosoma cruzi |
 (Eng)
|
Prates J., Lopes J., Chin C., Ferreira E., dos Santos J., Scarim C.
|
Volume 31, Nº 30 (2024) |
Discovery of Pyroptosis-inducing Drugs and Antineoplastic Activity based on the ROS/ER Stress/Pyroptosis Axis |
 (Eng)
|
Gan X., Xie J., Dong Z., Wu Y., Zeng X., Yang Z., Liu B., Zhu M., Wang B., Li W., Wang L., Zhang H., Wu J., Hu Y.
|
1 - 100 de 400 resultados |
1 2 3 4 > >> |